Viatris' generic of Symbicort (budesonide and formoterol ... one of the most commonly prescribed complex drug-device combination products to treat asthma and COPD is another step forward in ...
Symbicort was first FDA-approved in 2006 as a treatment for asthma, followed by an extension to its label covering COPD in 2009. A further approval in 2017 in childhood asthma has helped the drug ...
Drugmaker AstraZeneca said it intends to cap out-of-pocket prices of four medicines used to treat asthma and chronic ... Breztri and Symbicort will cost most patients no more than $35 a month ...
AstraZeneca also noted that it had "substantially" reduced the list price for Symbicort on Jan ... into the pricing of inhaler medications for asthma and COPD. The letter noted that Breztri ...
The fall and winter season typically brings an increase in asthma exacerbations in Massachusetts. During this time, circulating respiratory illnesses, such as flu, RSV, and COVID increase, can ...